Interleukin 1
-induced NF
B Activation and Chemokine mRNA Stabilization Diverge at IRAK1*
Justin Hartupee,
Xiaoxia Li, and
Thomas Hamilton1
From the
Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195
Interleukin 1
(IL-1
) is capable of driving pro-inflammatory gene expression through both the initiation of transcription and by prolonging the half-life of short-lived mRNAs. Although the signaling events linking the IL-1 receptor to the activation of NF
B and the initiation of transcription have been well characterized, less is known about the signaling events linking to mRNA stabilization. As a model to study the control of mRNA stability we have used the mouse chemokine KC, expression of which requires both NF
B-driven transcription and stabilization of the constitutively unstable mRNA. We have evaluated the role of signaling adaptors known to play a role in IL-1
-driven NF
B activation in the generation of mRNA stability. Surprisingly, although TRAF6 is essential for NF
B activation, it is not required for IL-1
-induced mRNA stabilization. IRAK1, which is recognized to function upstream of TRAF6, is required for both mRNA stabilization and activation of NF
B. Consistent with the previous findings, the TRAF6 interaction sites in IRAK1 are required for NF
B activation but do not play a role in mRNA stabilization. These findings indicate that signals from the IL-1 receptor segregate into at least two separate pathways at the level of IRAK1; one couples through TRAF6 to NF
B activation while a second utilizes a TRAF6-independent pathway that is responsible for mRNA stabilization.
Received for publication, February 20, 2008
, and in revised form, April 9, 2008.
* This work was supported by United States Public Health Service Grants CA39621 and T32GM007250. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Immunology, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. Tel.: 216-444-6246; Fax: 216-444-9329; E-mail: hamiltt{at}ccf.org.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Webpages:
F1000 Medicine *Recommended* - FREE!
This article has been cited by other articles:

|
 |

|
 |
 
Y. Wan, H. Xiao, J. Affolter, T. W. Kim, K. Bulek, S. Chaudhuri, D. Carlson, T. Hamilton, B. Mazumder, G. R. Stark, et al.
Interleukin-1 Receptor-associated Kinase 2 Is Critical for Lipopolysaccharide-mediated Post-transcriptional Control
J. Biol. Chem.,
April 17, 2009;
284(16):
10367 - 10375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hartupee, C. Liu, M. Novotny, D. Sun, X. Li, and T. A. Hamilton
IL-17 Signaling for mRNA Stabilization Does Not Require TNF Receptor-Associated Factor 6
J. Immunol.,
February 1, 2009;
182(3):
1660 - 1666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Eigenbrod, J.-H. Park, J. Harder, Y. Iwakura, and G. Nunez
Cutting Edge: Critical Role for Mesothelial Cells in Necrosis-Induced Inflammation through the Recognition of IL-1{alpha} Released from Dying Cells
J. Immunol.,
December 15, 2008;
181(12):
8194 - 8198.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.